Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
Titel:
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
Auteur:
Culine, Stéphane Fléchon, Aude Gravis, Gwenaelle Roubaud, Guilhem Loriot, Yohann Joly, Florence Barthélémy, Philippe Assaf, Elias Mahammedi, Hakim Beuzeboc, Philippe Houédé, Nadine Rolland, Frédéric Guillot, Aline Gross-Goupil, Marine Spano, Jean-Philippe Tartas, Sophie Deblock, Mathilde Chevreau, Christine Serrate, Camille Manduzio, Hélène Habibian, Muriel Thézénas, Simon Allory, Yves